EU seals deal for extra 1.8 bn BioNTech/Pfizer doses | The Guardian Nigeria News

5


(FILES) In this file photo taken on December 27, 2020 a medical worker shows a vial with the Pfizer-BioNTech Covid-19 vaccine at the corona vaccination centre at the Robert Bosch Hospital in Stuttgart, southern Germany. – Pfizer/BioNTech said on April 30, 2021, they have asked European regulators to authorise their Covid-19 vaccine for 12 to 15-year-old, following a similar move in the United States earlier this month. The companies have submitted a request with the European Medicines Agency (EMA) to expand the current emergency approval for their jab to include “adolescents 12 to 15 years of age”, they said in a statement. BioNTech CEO Ugur Sahin said on April 29 the jab could be available for those age groups from June. (Photo by THOMAS KIENZLE / AFP)

The EU has concluded a deal with BioNTech/Pfizer for up to 1.8 billion extra doses of their Covid-19 vaccine, European Commission chief Ursula von der Leyen said on Saturday.

“Happy to announce that the EU Commission has…



Source: Guardian Newspaper